MaxCyte, Inc. (MXCT)
NASDAQ·Healthcare·Medical - Devices
$0.88
+0.20%
Mkt Cap $93.35M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $9.08M | $7.30M | -19.64% | -$0.08 | -$0.06 | +25.00% | — | — |
| Q4 2025 Nov 12, 2025 | $9.40M | $6.83M | -27.37% | -$0.11 | -$0.12 | -9.09% | — | — |
| Q3 2025 Aug 6, 2025 | $10.36M | $8.51M | -17.89% | -$0.10 | -$0.12 | -20.00% | — | — |
| Q2 2025 May 7, 2025 | $9.57M | $10.39M | +8.59% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q1 2025 Mar 11, 2025 | $9.27M | $8.69M | -6.24% | -$0.12 | -$0.10 | +16.67% | — | — |
| Q4 2024 Nov 6, 2024 | $7.67M | $8.16M | +6.49% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q3 2024 Aug 6, 2024 | $7.37M | $10.43M | +41.51% | -$0.14 | -$0.09 | +35.71% | — | — |
| Q2 2024 May 7, 2024 | $7.46M | $11.34M | +52.04% | -$0.14 | -$0.09 | +35.71% | — | — |
| Q1 2024 Mar 12, 2024 | $13.09M | $15.67M | +19.68% | -$0.10 | -$0.05 | +50.00% | — | — |
| Q4 2023 Nov 8, 2023 | $9.41M | $8.00M | -14.94% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q3 2023 Aug 9, 2023 | $10.80M | $9.04M | -16.27% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q2 2023 May 10, 2023 | $10.79M | $8.58M | -20.52% | -$0.11 | -$0.11 | +0.00% | — | — |
| Q1 2023 Mar 15, 2023 | $8.32M | $12.42M | +49.32% | -$0.06 | -$0.05 | +16.67% | — | — |
| Q4 2022 Nov 9, 2022 | $10.43M | $10.64M | +2.04% | -$0.09 | -$0.06 | +33.33% | — | — |
| Q3 2022 Aug 10, 2022 | $9.23M | $9.61M | +4.09% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q2 2022 May 9, 2022 | $8.46M | $11.59M | +36.97% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q1 2022 Mar 22, 2022 | $9.56M | $10.15M | +6.17% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q4 2021 Nov 10, 2021 | $12.78M | $10.14M | -20.63% | -$0.05 | -$0.03 | +40.00% | — | — |
| Q3 2021 Sep 13, 2021 | — | $7.11M | — | -$0.05 | -$0.05 | +0.00% | — | — |
| Q3 2021 Jul 30, 2021 | — | $6.49M | — | — | -$0.09 | — | — | — |